Complex cisplatin-double strand break (DSB) lesions directly impair cellular non-homologous end-joining (NHEJ) independent of downstream damage response (DDR) pathways

Research output: Contribution to journalArticle

28 Scopus citations

Fingerprint Dive into the research topics of 'Complex cisplatin-double strand break (DSB) lesions directly impair cellular non-homologous end-joining (NHEJ) independent of downstream damage response (DDR) pathways'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences